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ABSTRACT
In this work, scaffolds derived from a new biomaterial originated from the combination of a natural
material and a synthetic material were tested for assessing their suitability for cartilage tissue engi-
neering applications. In order to obtain a better outcome result in terms of scaffolds’ overall properties,
different blends of natural and synthetic materials were created. Chitosan and polybutylene succinate (C-
PBS) 50/50 (wt%) were melt blended using a twin-screw extruder and processed into 555 mm scaf-
folds by compression moulding with salt leaching. Micro-computed tomography analysis calculated an
average of 66.29% porosity and 92.78% interconnectivity degree for the presented scaffolds. The salt
particles used ranged in size between 63 and 125 lm, retrieving an average pore size of 251.28lm.
Regarding the mechanical properties, the compressive modulus was of 1.73 ± 0.4 MPa (Esec 1%). Cyto-
toxicity evaluation revealed that the leachables released by the developed porous structures were not
harmful to the cells and hence were noncytotoxic. Direct contact assays were carried out using a mouse
bone marrow–derived mesenchymal progenitor cell line (BMC9). Cells were seeded at a density of 5105
cells/scaffold and allowed to grow for periods up to 3 weeks under chondrogenic differentiating condi-
tions. Scanning electron microscopy analysis revealed that the cells were able to proliferate and colonize
the scaffold structure, and MTS test demonstrated cell viability during the time of the experiment.
Finally, Western blot performed for collagen type II, a natural cartilage extracellular matrix component,
showed that this protein was being expressed by the end of 3 weeks, which seems to indicate that the
BMC9 cells were being differentiated toward the chondrogenic pathway. These results indicate the
adequacy of these newly developed C-PBS scaffolds for supporting cell growth and differentiation toward
the chondrogenic pathway, suggesting that they should be considered for further studies in the cartilage
tissue engineering field.
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INTRODUCTION
TRAUMA AND DISEASE OF BONE and joints, frequently in-volving structural damage to both the articular cartilage
surface and the subchondral bone, result in severe pain and
disability for millions of people worldwide. Such problems
were initially addressed by performing different surgical pro-
cedures, which included debridement, drilling, abrasion
arthroplasty, and microfracture.1,2 Some of these clinical ex-
periments turnedout tobesuccessful insomecases,andare still
being performed in hospitals and clinics throughout the world,
but most of their outcomes are variable and dependent on a
wide range of factors that can limit its wider application.3,4
Tissue engineering was brought up as a new way to ad-
dress these problems and grew as a new field of knowledge
not only in cartilage regeneration but also in several other
types of tissue.5–7 The fundamental goal of tissue engi-
neering is to develop biological substitutes that restore,
maintain, or improve tissue function and to apply these to
clinical scenarios where tissue is lost through trauma or
disease.8 The cell support structure—a scaffold—should
serve as a three-dimensional template for initial cell at-
tachment and subsequent tissue formation, both in vitro and
in vivo. It must not trigger strong immunological responses
or cause severe cytotoxicity effects, and should present
mechanical properties similar to the tissue of interest.5
Scaffolds are made of materials that can be broadly di-
vided into synthetic and natural.9,10 Synthetic polymers
include the polylactides, such as polylactic acid (PLA)9 and
polyglycolic acid (PGA),11 although a wide range of others
such as polyethylene oxide (PEO),12 poly(lactic-co-
glycolic) PLGA,13 and poly-2-hydroxyethyl methacrylate
(PHEMA)14 exist. Even though they possess some con-
trollable and advantageous features, such as reproducible
manufacturing at a large scale and controlled degradation
time, they also have several disadvantages, like the lack of
cell-recognition signals. Further, specific features of some
polymers, like the acidic by-products released by PLA, for
example, pose additional difficulties to their use.15
Natural-origin materials seem to overcome some of these
limitations.16,17 Most of them are normal components of the
tissue to be regenerated, possess specific sites for cell rec-
ognition, and share some similarities with the native tissue
components.18–20 Collagen,19 hyaluronic acid,18 chit-
osan,10,20 and starch21 are examples of those materials. The
conjugation of natural and synthetic materials in the fabri-
cation of a scaffold taking advantage of the individual fea-
tures of each one is a strategy that has been tried by different
research groups. Chen et al. produced a hybrid mesh of
PLGA and collagen that enabled the aggregation of mes-
enchymal stem cells and provided them with a microenvi-
ronment that allowed chondrogenic differentiation to
occur.22 In another study, Wang et al. fabricated a hybrid
matrix based on polyglycolide and chitosan that allowed
fibroblast proliferation and revealed promising further tissue
engineering applications.23
In this work, scaffolds of a blend of chitosan (a natural
polymer derived from the deacetylation of chitin) and poly-
butylene succinate (a synthetic polymer) were produced and
put through preliminary in vitro tests. The rationale is to
combine the biological properties of chitosan with the me-
chanical support conferred by polybutylene succinate, ex-
pecting this will render a better performance to the tissue-
engineered construct once implanted. Chitosan is a partially
deacetylated derivative of chitin, which is the primary
structural polymer in arthropod exoskeletons, shells of
crustaceans, and the cuticles of insects.24 Chitosan is a
semicrystalline polysaccharide that is normally insoluble in
aqueous solutions above pH 7. However, in dilute acids
(pH 6), the free amine groups are protonated and the mole-
cule becomes soluble. This pH-dependent solubility provides
a convenient mechanism for processing under mild condi-
tions.25 Chitosan is reported to be nontoxic, biodegradable,
and biocompatible,26 and has structural similarities to glycos-
aminoglycans, which are structural components of the car-
tilage extracellular matrix.27 It serves different applications,
and its use ranges from the food industry to the biomedical
and pharmaceutical fields.28,29 Polybutylene succinate is one
of the most accessible biodegradable polymers, and has been
extensively studied for its potential use as a future conven-
tional plastic, serving also as a support for different ap-
proaches in the medical field.30,31 It is an aliphatic polyester
presenting good processability and flexibility, and having
degradation products that are nontoxic and can enter the
metabolic cycles of bioorganisms. Its conjugation with
chitosan aims at providing mechanical support to the scaf-
fold, which should be advantageous considering the clinical
scenario of constant load-bearing efforts in articular carti-
lage. Little research has been conducted in the melt blending
of synthetic polyesters and chitosan,26 and the preliminary
results described herein for their use as potential scaffolds for
cartilage regeneration are important. The herein developed
chitosan and polybutylene succinate (C-PBS) scaffolds were
seeded with cells originated from a mouse mesenchymal
stem cell line (BMC9)32 and cultured under chondrogenic
inductive conditions, in order to assess their suitability for
cartilage tissue engineering approaches.
MATERIALS AND METHODS
Scaffold production and processing
The chitosan/polybutylene succinate 50/50 (%wt) blend
was compounded in a twin screw extruder. The details of
the processing conditions are summarized elsewhere.26 The
methodology used for the scaffold production was based on
compression moulding followed by salt leaching. Before
using it in the scaffold processing, the salt was ground and
sieved to obtain particles with size between 63 mm<
d< 125 mm. The compounded polymeric blend was ground,
mixed with salt, and compression molded into discs. The salt
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content was 80% by weight. The discs were cut into 55
5 mm cubes. These cubes were then immersed in distilled
water to leach out the salt, dried, and used for cell culture and
proliferation studies after sterilization by ethylene oxide.
Scaffold characterization
The C-PBS scaffold structure was analyzed by scanning
electron microscopy (SEM) using a Leica Cambridge S360
(Leica Cambridge, Cambridge, UK). Micro-computed to-
mography (m-CT) equipment (SkyScan, Kortich, Belgium)
was used for more detailed analysis of the morphology of
the developed scaffolds, and CT Analyser and CT Vol
Realistic 3D Visualization were used as image-processing
softwares, both from SkyScan. Uniaxial compression tests
were performed to assess the mechanical properties of the
scaffolds (dry state) using a Universal tensile testing ma-
chine (Instron 4505 Universal Machine, Instron, Norwood,
MA). The details regarding these methods are presented
elsewhere.26
In vitro cytotoxicity tests
To assess the short-term cytotoxicity of the developed
C-PBSscaffolds, minimum essential medium (MEM) extrac-
tion and 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxy-
phenyl)-2(4-sulfofenyl)-2H-tetrazolium (MTS) tests, both
within a 24 h extraction period, according to ISO/EN 10993
part 5 guidelines,33 were used in order to establish the possi-
ble toxic effects of leachables released from the scaffolds
during extraction. Latex rubber was used as positive control
for cell death due to its high cytotoxicity to cells, and culture
medium was used as a negative control representing the ideal
situation for cell proliferation. The results are presented after
normalization with the negative control. The objectives of
the MEM extraction test are to evaluate changes in cell
morphology and growth inhibition, whereas the MTS test
determines whether cells are metabolically active.
Cell culture. A rat lung fibroblast cell line, L929, acquired
from the European Collection of Cell Cultures (ECACC),
was used. The cells were grown as monolayers in Dulbec-
co’s modified Eagle’s medium (DMEM; Sigma, St. Louis,
MO) supplemented with 10% fetal bovine serum (FBS;
Biochrom, Berlin, Germany) and 1% of an antibiotic–
antimycotic mixture (Sigma). Trypsin (Sigma) was used to
detach the cells from the culture flasks before the experi-
ments were conducted.
MEM extraction test. The ratio of material weight to
extract fluid was constant and equal to 0.2 g/mL for porous
samples. For the positive control the ratio of material outer
surface to extraction fluid was 2.5 cm2/mL. Test material
(n¼ 6) and positive control were extracted for 24 h at 378C,
using complete culture medium as extraction fluid. Before
the tests, culture medium was removed from the wells and an
identical volume (2 mL) of extraction fluid was added. For
the MEM extraction test, the cells were seeded in 24-well
plates (n¼ 3) at a density of 1.25105 cells/well. Then they
were incubated for 24 h at 378C in a humidified atmosphere
with 5% CO2. Cell response was evaluated after 24, 48, and
72 h of incubation. Confluence of the monolayer, degree of
floating cells, and changes in morphology were analyzed by
visual observation. After 72 h, the percentage of growth
inhibition was determined by cell counting with a hemocy-
tometer and trypan blue exclusion method. Final measure-
ments were corrected for the negative control.
MTS test. For the MTS test, cells were seeded in 96-well
plates (n¼ 6) at a density of 1.8104 cells/well. Then they
were incubated for 24 h at 378C in a humidified atmosphere
with 5% CO2. As referred, the MTS was performed to
evaluate the cytotoxic effects of the developed scaffolds.
A CellTiter 96 One solution Cell Proliferation Assay kit
(Promega, Madison, WI) was used. It is based on the bio-
reduction of the substrate MTS into a brown formazan
product by dehydrogenase enzymes in metabolically active
cells, and is commonly used for cell viability evaluation.
Briefly, the procedure was conducted as follows. The ex-
traction procedure was the same as described previously for
the MEM extraction test, using 200 mL of extraction fluid
per well. After 72 h, the extraction fluid was removed and
200 mL of a mixture containing serum-free culture medium
without phenol red, and MTS was added to each well. Cells
were then incubated for 3 h at 378C in a humidified atmos-
phere containing 5% CO2. After this, optical density (OD)
was measured with a plate reader (Molecular Devices,
Sunnyvale, CA) at 490 nm. The mean OD value obtained
was standardized taking into account the values for the
negative control. Statistical analyses were conducted using
a two-sample t-test assuming unequal variances for n¼ 3
and a¼ 0.05.
Direct contact assays
Cell seeding and culturing. For the direct contact assays,
a mouse mesenchymal progenitor cell line (BMC9) was
used. The BMC9 cell line has been shown to exhibit four
mesenchymal cell phenotypes: chondrocytic, adipocytic,
stromal (supports osteoclast formation), and osteoblastic.32
The cells were grown as monolayer cultures in a culture
medium consisting of a-MEM (Sigma), 10% FBS, and 1%
A/B (penicillin G sodium 10,000 U/mL, amphotericine B
Fungizone (Invitrogen, Carlsbad, CA) 25 mg/mL, and
streptomycin sulfate 10,000 mg/mL, in 0.85% saline). When
the adequate cell number was obtained, cells at passage 9
(P9) were trypsinized, centrifuged, and resuspended in cell
culture medium. Cells were seeded at a density of 5105
cells/scaffold (555 mm3) under static conditions, using
for this purpose aliquots of 15 mL loaded on top of the
scaffolds that had been previously placed in 24-well culture
plates. Two hours after seeding, 1 mL of culture medium
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was added to each well and the cell-seeded scaffolds were
allowed to develop for periods up to 3 weeks, in a humidified
atmosphere at 378C, containing 5% CO2, under chondrogenic
differentiation inducing medium. This culturing medium
consisted of DMEM (Sigma), dexamethasone (Sigma) 1.0
104 M, sodium pyruvate (Sigma) 1.0103 M, ascorbate-
2-phosphate (Sigma) 0.17 mM, proline (Sigma) 0.35 mM,
ITS 1 (Sigma), and hBMP-2 (R&D BioSystems, Min-
neapolis, MN) 100 ng/mL. The culture medium was chan-
ged every 3 to 4 days until the end of the experiment.
Cellular viability by MTS test. The principle of the MTS
test has already been previously herein described for the
in vitro cytotoxicity tests. The MTS test was performed for
the cell-seeded scaffolds for different time periods, spe-
cifically 1, 2, and 3 weeks. Briefly, the procedure is as
follows. The cell-seeded C-PBS scaffolds (n¼ 3) were
rinsed in 0.15 M phosphate-buffered saline (Sigma) and
immersed in a mixture consisting of serum-free cell culture
medium and MTS reagent at 5:1 ratio. Incubation for 3 h at
378C in a humidified atmosphere containing 5% CO2 fol-
lowed. After this, 100 mL were transferred to 96-well plates
and the OD determined at 490 nm. Controls consisting of
scaffolds without any cells seeded were also used. Statis-
tical analyses were conducted using a two-sample t-test
assuming unequal variances for n¼ 3 and a¼ 0.05.
Cell adhesion and morphology by SEM. Cell adhesion,
morphology, and average distribution were observed by
SEM analysis. The cell–scaffold constructs were washed in
0.15 M phosphate-buffered saline and fixed in 2.5% glutar-
aldehyde (in phosphate-buffered saline). The constructs
were then rinsed three times in phosphate-buffered saline,
and subjected to a series of ethanol increasing conditions
(30%, 50%, 70%, 90%, and 100% ethanol), 10–15 min each,
to allow dehydration of the samples. The samples were let to
air dry afterward, and then sputter coated with gold ( JEOL
JFC-1100) and analyzed with a Leica Cambridge S360
scanning electron microscope.
Western blot: collagen type II. For the protein extraction,
the cell–scaffold constructs (n¼ 3) were washed in 0.15 M
phosphate-buffered saline, lysed in 750 mL of lysis buffer
(20 mM Tris, 1 mM EDTA, 150 mM NaCl, and Triton X-
100), and sonicated three times at 40 kV (15 s). After soni-
cation the C-PBS scaffolds were removed and the resulting
suspension was centrifuged for 10 min at 13,000 rpm and
48C, at the end of which the formed pellet was discarded.
The supernatants containing the protein fraction were stored
for quantification. Western blot was performed using the
protein extracts collected at 3 weeks. A 5% stacking poly-
acrylamide gel (30% acrylamide mix, 1.0 M Tris (pH 6.8),
10% SDS, 10% ammonium persulfate, and TEMED) and an
8% resolving gel (30% acrylamide mix, 1.5 M Tris (pH 8.8),
10% SDS, 10% ammonium persulfate, and TEMED) were
prepared. The collected supernatant was heated at 1008C for
5 min in the water bath, and then an aliquot (15.64 mL)
was loaded in the gels and subjected to electrophoresis
(30 mA, 3 h) and electrotransferred to a Hybond P mem-
brane (Amersham Biosciences, Piscataway, NJ). Afterward,
the membrane was washed in phosphate-buffered saline-
Tris, submerged in Coomassie blue (isopropylic alcohol
0.25% (v/v), acetic acid 0.1% (v/v), and Coomassie Bril-
liant Blue R250 2 g/L), and left overnight. The membrane
was washed in Ponceau solution, and the transfer from the
gel to the membrane was visually confirmed. Membranes
were then incubated with a blocking solution of 5% (wt/v)
powdered milk in TBS (Tris base 2.42 g/L, NaCl 8 g/L, and
HCl 3.8 g/L) with Triton X-100 0.002% (v/v), for 1 h under
constant stirring at room temperature. Incubation with an
equal solution followed, but altering the powdered
milk concentration to 2.5% (wt/v). This solution also in-
cluded the primary antibody against collagen type II
(University of Iowa, Iowa City, IA) at a 1:500 dilution. The
membrane was left overnight with constant stirring at 48C.
The membrane was then washed three times in phosphate-
buffered saline-Tris under stirring,and incubated with thesec-
ondary antibody (1/1000) for 1 h at room temperature, under
stirring. The secondary antibody was diluted in the same
solution as the one described above for the primary antibody.
The membranes were washed three times in phosphate-
buffered saline-Tris and passed to a phosphate-buffered
saline solution. The immune complex was detected by in-
cubation of the membrane as described in SuperSignal
Pico Chemiluminescent Substrate kit (Pierce, Rockford, IL).
RESULTS
Scaffold characterization
As seen in the SEM and m-CT images (Figs. 1 and 2,
respectively), the structure of the processed C-PBS scaffolds
FIG. 1. SEM micrograph showing the surface of a chitosan–
polybutylene succinate scaffold 50:50 (wt%), with 80% porosity.
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appears to be quite interconnected (Fig. 2) and with suit-
able pore size to provide support for cell growth and de-
velopment. m-CT analysis calculated an average of 66.29%
( 2.55%) porosity and 92.78% ( 1.69%) interconnectivity
degree for these C-PBS scaffolds. The salt particles used
ranged in size between 63 and 125 mm, retrieving an average
pore size of 251.28 mm ( 61. 9 mm). In terms of mechanical
properties, the scaffolds exhibited a compressive modulus of
1.73 0.4 MPa (Esec 1%).
In vitro cytotoxicity tests (MEM
extraction and MTS tests)
Regarding the MEM extraction test, the results showed that
the materials did not cause any morphological changes or
induce any deleterious alteration to the metabolic activity of
L929 cells and thus can be considered noncytotoxic. There
was no growth inhibition detected after the 72 h time period
(0.0 0.0%) when using the trypan blue exclusion method.
The negative control did not affect cell proliferation and
morphology, and a monolayer of spread cells was observed.
The toxic effect of the positive control (latex) was evident,
given the severe changes on morphology and the inability of
cells to proliferate. The extracts from the C-PBS scaffolds did
not exert any deleterious effect on L929 cells morphology,
presenting morphological and proliferative features similar to
those encountered for the negative controls (data not shown).
Concerning the MTS test, L929 cells were able to metabolize
the MTS into a brown formazan product after a 72 h incu-
bation period with the collected extracts and the values ob-
tained were similar to the negative control (Fig. 3).
Direct contact assays
Direct contact assays were performed to evaluate BMC9
cell response to the C-PBS scaffolds. MTS was performed to
assess cell viability at defined time periods, specifically 1, 2,
and 3 weeks. Figure 4 represents the obtained results, where
it can be observed that the cells were able to remain viable
within the C-PBS scaffolds during the whole time of the
experiments. The values were higher than the control for all
time points and had a significant increase ( p< 0.05) from 1
week to 2 weeks, which is a good indicator of cell viability.
At 3 weeks, a significant decrease ( p< 0.05) is observed in
the OD values.
SEM analysis (Figs. 5–7) evidenced that BMC9 cells were
well adhered onto the C-PBS scaffold surface, and appeared
to be morphologically normal throughout the whole time of
the experiments. Further, a morphological transition in these
cells was observed from an initial fibroblastic-like shape to
a round-shaped phenotype, which is a feature present in
articular cartilage chondrocytes that underwent culturing
under 2D conditions.34 From the SEM picture at 1 week, it is
clear that cells adhered to the scaffolds and spread along its
structure (Fig. 5A), forming multilayers (Fig. 5B). Cell
FIG. 2. m-CT image evidencing the structure and inter-
connectivity of the processed chitosan–polybutylene succinate
scaffold 50:50 (wt%), with 80% porosity scaffolds.
FIG. 3. Graphical representation of the results obtained after
cytotoxicity evaluation of the processed scaffolds (MTS test)
using L929 cells, derived from a rat lung fibroblast cell line.
Statistical analyses were conducted using a two-sample t-test as-
suming unequal variances for n¼ 3 and a¼ 0.05.
FIG. 4. Graphical representation of the results obtained after
performing MTS test with samples taken at 1, 2, and 3 weeks of
culturing with BMC9 cells. Statistical analyses were conducted
using a two-sample t-test assuming unequal variances for n¼ 3
and a¼ 0.05.
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morphology is still clearly fibroblastic-like, with extensive
cell-to-cell interactions.
After 2 weeks of culture, cell morphology passed from the
initial fibroblastic-like shape with some evident cytoplasmic
membrane extensions to a round-shaped phenotype, as shown
in Figure 6A and B. SEM analysis also revealed that the
chondrocyte-like cells were widely present in the pores of the
scaffolds, as shown by a representative example in Figure 6E.
After 3 weeks, almost all the cells exhibited a round-
shaped phenotype and were widely distributed throughout
the scaffold (Fig. 7). Further, on the cell surface, some
structures previously described as collagen fibrils35 were
observed (Fig. 7D, arrows). Even though speculative, one
may correlate this observation with the results shown af-
terward for collagen type II expression, performed by
Western blot immunological analysis.
FIG. 6. SEM micrographs of 2 weeks of culturing (A–F). We can observe the cell morphological transition, passing from the initial
fibroblastic-like shape with some evident cytoplasmic membrane extensions to a round-shaped phenotype, as evidenced in (A) and (B).
FIG. 5. SEM micrographs of 1 week of culturing (A, B), showing that BMC9 cells were able to adhere and appear to remain viable
within the scaffold structure.
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Western blot analysis at 3 weeks (Fig. 8) demonstrated
that collagen II was being expressed, which is a good in-
dicator for the successful differentiation of the BMC9 cells
toward the chondrogenic pathway, and suggests at the
same time that cartilage-like extracellular matrix was be-
ing produced as suggested from the SEM micrograph
observations (Fig. 7). The band obtained correlates with
data presented in the literature for collagen type II
protein.36,37
DISCUSSION
In this work, scaffolds produced from a blend of chitosan
and polybutylene succinate were tested for assessing their
suitability for cartilage tissue engineering applications. The
scaffolds were characterized to evaluate their potential for
future uses in the cartilage regeneration field by employing
techniques such as m-CT and performing their mechanical
behavior evaluation. Their cytotoxicity was determined, and
in a final stage the direct contact with BMC9 cells under
chondrogenic differentiating conditions was conducted, as
well as analysis of their differentiation status. Considering
the salt particle sizes used (63–125 mm), one would expect
that the created pores after the salt leaching step will be
within this range. Nevertheless, some disperse particle ag-
glomerations take place during processing, creating there-
fore bigger pore sizes, which may arise as an advantage
regarding interconnectivity. In fact, results show that the
scaffolds present a high range of pore sizes exhibiting a
251.28 mm average pore size with a  61.9 mm standard
deviation. These measurements show that pores of less than
100 mm and more than 300 mm are also present in the scaf-
folds, granting them greater versatility in terms of pore size
profiles for cells to distribute. The average porosity of
66.29% ( 2.55%) is also adequate and quite interesting
considering the processing technology used, while the
92.78% ( 1.69%) interconnectivity degree renders these
scaffolds with a quite interconnected structure, thereby en-
abling seeded cells to proliferate and establish communi-
cation paths throughout the 3D support, as well as allowing
nutrients and metabolic waste flow to be conducted. Such
data prompt these C-PBS scaffolds to go through further
screenings in order to evaluate their potential in the gener-
ation of a functional cartilage tissue-engineered construct.
The mechanical properties of the scaffolds disclosed values
FIG. 7. SEM micrographs showing BMC9 cells onto the developed scaffolds at 3 weeks (A–D). Most cells exhibited a round-shaped
phenotype and were widely distributed throughout the scaffold (C). Structures previously described as collagen fibrils are indicated by
white arrows.
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that are in the range of those shown in the literature for
human articular cartilage38, which is an indication of the
suitability of the C-PBS scaffolds in terms of mechanical
performance for cartilage regeneration strategies. In an
in vivo scenario, the authors expect a balance between
chitosan absorption by the organism, and cells proliferation
and tissue ingrowth, in such a way that the mechanical
support and biological role of the structures are constantly
maintained. Cytotoxicity evaluation performed using MEM
and MTS tests showed that the C-PBS were noncytotoxic.
The leachables released from the scaffolds did not cause any
severe alteration to the L929 cell metabolism, thereby re-
inforcing their adequacy for moving through further studies
in the regeneration of cartilaginous tissues. The following
step involved the direct contact of cells with the fabricated
C-PBS scaffolds. The cells used were derived from a mouse
mesenchymal stem cell line (BMC9), and these were cul-
tured under chondrogenic inductive conditions onto the
C-PBS scaffolds, assessing in this way the suitability of
these systems in future cartilage regeneration studies. Bone
morphogenetic protein type 2 (BMP-2) was used as the
promoting agent for chondrogenic differentiation. BMP-2 is
a protein belonging to the TGF-b superfamily that can
stimulate the chondrogenic lineage development of cells
from mesenchymal origin, and its inclusion was a key factor
in cell differentiation. The cell seeding was performed using
the cell drop seeding method, which is currently used for
seeding cells into scaffolds. Although it is disadvantageous
in terms of cell seeding homogeneity throughout the support
structure, it is a good way to perform a first evaluation of
how the cells react once in contact with the proposed scaf-
folds. In the case of the C-PBS, although this method gives
rise to an inhomogeneous cell distribution, it was observed
that the scaffold surface was highly colonized throughout the
time of the experiments. When analyzing the MTS results, it
is possible to observe that the values were higher than the
control for all time points and had a significant increase
( p< 0.05) from 1 week to 2 weeks, which is a good indicator
of cell viability. This may be the consequence of two factors:
either the cells are proliferating and thereby more MTS is
metabolized, justifying therefore the higher OD values, or
the proliferation rates are not that high, but on the other hand
the mitochondrial machinery is highly active, converting
therefore higher amounts of MTS. Any combination of these
two situations is possible, but either mechanism is indicative
of cell viability within the scaffold structure. This fact is
highly relevant for the following steps because although the
leachables released from the scaffolds did not present any
in vitro cytotoxicity, the direct cell contact with the struc-
tures could be affected by factors such as surface chemistry,
topography, and wettability, which were shown not to occur.
At 3 weeks, a significant decrease ( p< 0.05) is observed in
the OD values, which may be directly related to normal
changes in cell metabolism, given that the active protein
synthesis normally associated with this stage usually implies
a decrease in cellular proliferation. As the mitochondria
have a prominent role in cell growth, the reduction in their
activity leads to a diminished metabolization of the MTS.
The C-PBS scaffolds appear to be able to support BMC9 cell
proliferation and differentiation toward the chondrogenic
lineage, once subjected to the specific medium used which
contained BMP-2. This occurrence was observed by SEM
after 2 weeks of culture, since the cells passed from an initial
fibroblast to a more round chondrocyte-like morphology. In
fact, this situation is similar to the one obtained when
growing primary culture chondrocytes under a 2D environ-
ment for extended periods of time. Initially, the chon-
FIG. 8. Western blot analysis performed for collagen type II.
The band obtained correlates with data presented in the litera-
ture for collagen type II protein (approximately 100 kDa). Col-
lagen type II expression is a good indicator for the successful
differentiation of the BMC9 cells toward the chondrogenic
lineage.
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drocytes dedifferentiate and adopt a more fibroblastic-like
phenotype, with alteration in protein expression, decreasing,
for example, collagen type II expression and increasing
collagen type I.34,39 Nevertheless, once confluence is reached
under a 2D environment, cells start to pack themselves into
multilayers, reflecting a consequence of high cell density
culturing, and start to regain their globular morphology. In
fact, this multilayered arrangement somehow mimics a 3D
environment such as the one created under pellet or 3D
support cultures. Once this change takes place, protein ex-
pression patterns also modify, and, for example, collagen
type II levels increase again. In this work, this change in
morphology is an indication for a possible BMC9 cell
chondrogenic lineage differentiation. This was an expected
result due to the culturing of the cells in a 3D environment
supplied with BMP-2. Further, on the cell surface, some
structures previously described as collagen fibrils35 were
observed (Fig. 7D, arrows). Even though speculative, one
may correlate this observation with the results shown af-
terward for collagen type II expression, performed by
Western blot immunological analysis. Finally, Western blot
analysis after 3 weeks (Fig. 8) demonstrated that collagen
type II was being expressed, which is a good indicator for
the successful differentiation of the BMC9 cells toward
the chondrogenic pathway, and suggests at the same time
that cartilage-like extracellular matrix was being produced
as suggested from the SEM micrograph observations
(Fig. 7). The band obtained correlates with data presented in
the literature for collagen type II protein.36,37 Given the
mesenchymal progenitor origin of BMC9 cells, which
have not been shown to normally express collagen type II,
this result leads us to believe that the cells were actually
being directed toward the chondrogenic lineage. As a pre-
liminary screening, such suggestions are indeed important
for the future application of these systems in cartilage re-
generation approaches. The results obtained so far show
that these C-PBS scaffolds have fulfilled the basic re-
quirements to be put through sequential testing. This work
revealed that they can support the growth and differen-
tiation of undifferentiated cells and create an environment
suitable for their chondrogenic differentiation. These re-
sults can be considered as a base for following experi-
ments that can combine undifferentiated cells from other
sources, direct them toward the chondrogenic lineage, and
culture them in vitro for adequate periods so that a func-
tional tissue-engineered construct is formed. This possesses
the mechanical stability provided by polybutylene succi-
nate and the biological similarity properties conferred by
chitosan.
CONCLUSIONS
In the present work, it was observed that scaffolds made of
a blend of chitosan and polybutylene succinate 50:50 (%wt)
are adequate to be used in cartilage tissue engineering ap-
proaches. These scaffolds were shown to present mechanical
properties and morphological features suitable for cell de-
velopment and to be noncytotoxic and cytocompatible. Di-
rect contact assays evidenced that cells from a mouse
mesenchymal progenitor cell line (BMC9) were able to
adhere to the scaffold surface and penetrate its pores, as well
as remaining viable for at least 3 weeks of culturing. SEM
analysis indicated that the cells were directed toward the
chondrogenic lineage due to observed morphological tran-
sitions occurring around 2 weeks of culture. This was one of
the expected outcomes, due to the 3D environment onto
which the cells were cultured, as well as the specific medium
used, which contained BMP-2. BMC9 cell chondrogenic
differentiation was further corroborated by the collagen type
II expression obtained after 3 weeks of culturing. The ob-
tained data so far present good perspectives for the use of
chitosan and polybutylene succinate scaffolds in cartilage
regeneration approaches.
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